SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane

SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
复制标题

DOI:
10.1186/s13046-020-01577-z
复制
发表时间:
2020
期刊:
Journal of Experimental & Clinical Cancer Research
影响因子:
--
通讯作者:
王海河
王海河
中科院分区:
--
文献类型:
--
作者:
Li H;Zhang M;Wei Y;Haider F;Lin Y;Guan W;Liu Y;Zhang S;Yuan R;Yang X;Yang S;王海河

文献摘要

相似文献